Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Oct 6.
Published in final edited form as: Am J Psychiatry. 2023 Oct 1;180(10):708–711. doi: 10.1176/appi.ajp.20230630

Maternal perinatal stress is associated with offspring negative emotionality, but the underlying mechanisms remain elusive

Alexander J Shackman 1,2,3, Dylan G Gee 4
PMCID: PMC10558087  NIHMSID: NIHMS1924253  PMID: 37777854

COMMENTARY

Anxiety and depression—the internalizing disorders—typically emerge in the first three decades of life (1, 2). They are among the most prevalent and burdensome mental illnesses, afflicting ~580M individuals worldwide (3, 4). In the U.S., nearly 1 in 3 individuals will experience a lifetime anxiety disorder (5) and 1 in 5 will experience a depression disorder (6). Direct healthcare costs exceed $100B annually (7). Existing treatments are far from curative for many, fueling the search for new etiological insights and new targets for intervention (8-14).

The roots of internalizing illness extend into the earliest chapters of human development, when the brain and behavior are likely most plastic. There is ample evidence that caregiver behavior in the first half-decade of life can have a profound and enduring impact on both neurobiological and psychological development and, ultimately, on lifelong health and wellbeing (15-17). The consistent provision of supportive, sensitive, and engaged care is an essential ingredient in healthy emotional development and provides a buffer against the potentially toxic effects of childhood challenges, setbacks, and adversities (15, 18). Not surprisingly, clinicians and researchers have shown a longstanding interest in understanding the role of parents and other caregivers in the development, treatment, and prevention of internalizing disorders (16). Recent work highlights the potentially important role of perinatal caregiver stress in promoting child psychopathology, but the exact nature of this association has remained unclear (15, 19).

From this perspective, the new report from Marr and colleagues in this issue of the Journal is a welcome addition to the literature (20). Leveraging a composite index of maternal stress that was repeatedly assessed across pregnancy and the early postnatal period in a small, but demographically diverse sample of American mothers (n=115), the authors used an innovative machine-learning approach to identify—in a completely data-driven way—six prototypical patterns of perinatal maternal stress (21). Two of the patterns predominantly reflected overall differences in stress severity, effectively clustering the mothers into groups with comparatively high or low levels of stress. The other 4 patterns reflected differences in the temporal dynamics of perinatal stress. Here, the mothers were split into groups characterized by distinct stress trajectories, including a mid-pregnancy peak (Trajectory 2), a late-pregnancy peak (Trajectory 1), a mid-/late-pregnancy trough (Trajectory 3), and an inverted-U pattern (Trajectory 4). Follow-up analyses demonstrated that the four stress-trajectory groups were demographically indistinguishable, suggesting that this novel classification might provide a useful additional source of information about children’s early-life experience. But are the trajectories a reproducible feature of maternal experience or simply an idiosyncratic feature of the data at hand? A key strength of Marr and colleagues’ study was the use of a second, much larger sample of Finnish mothers to address this key question (n=2,156). Of the four stress trajectories identified in the U.S. sample, Trajectories 1-3 replicated in the Finnish sample.

To clarify the consequences of mothers’ perinatal stress on their infant’s emotional development, Marr and colleagues modeled prospective associations between the replicable stress patterns and measures of infant negative emotionality acquired longitudinally over the first two years of life (22). Negative emotionality is a particularly interesting phenotype because children who are prone to feelings of fear, irritability, and sadness are more likely to develop internalizing disorders and other forms of psychopathology as they grow older (16, 23-25). Latent growth curve analyses indicated that the average level of infant negative emotionality showed a developmentally appropriate increase across the first year of life, before declining in the second (26). Among the various stress patterns examined, Trajectory 3 (mid-/late-pregnancy trough in maternal stress) was uniquely associated with longitudinal changes in offspring negative emotionality. Follow-up analyses demonstrated that the infants of Trajectory-3 mothers showed significantly lower levels of negative emotionality—relative to all of the other infants—by the end of their first year. Consistent with the American results, the offspring of Trajectory-3 mothers in Finland showed consistently dampened levels of negative emotionality across their first two years, with the differences reaching significance at 6, 12, and 24 months. In short, American and Finnish mothers reporting a trough in stress during the middle and late stages of pregnancy gave birth to children with lower levels of dispositional fear, shyness, anger, and sadness as infants and toddlers, and this prospective association could not be explained by demographic confounds, the average severity of stress experienced during pregnancy, or the intensity of stress experienced by mothers during the postpartum follow-up period. These observations—which capitalize on over 2,000 families, drawn from two continents, and intensively studied for nearly three years—motivate the hypothesis that diminished levels of maternal stress in the later stages of pregnancy foster the development of children who are less likely to develop emotional disorders later in life. They reinforce the idea that “timing matters” when it comes to early-life stress, and are well aligned with recent commentaries emphasizing the importance of parsing heterogeneity in both the nature and the developmental timing of stress for understanding psychopathology (15, 27-30).

At first blush, Marr and colleagues’ findings seem to reinforce calls for an increased investment in interventions aimed at strengthening early-life caregiving and maternal wellbeing (15), but they also raise questions about whom to target. On the one hand, across the six perinatal stress patterns identified by Marr’s team, only Trajectory 3—comprising less than a quarter of the American families (22.6%)—was consistently associated with variation in offspring temperament, after controlling for on-going levels of postpartum maternal stress. On the other hand, in analyses that did not control for postpartum maternal stress, the overall severity of perinatal stress was associated with significantly elevated infant negative emotionality. These findings suggest that mothers who report chronically high levels of stress, whether before or after giving birth, have children who are at greater risk for developing emotional disorders. The latter results are consistent with a wealth of other work and motivate the development and refinement of targeted, universal, and public-policy interventions (15, 19). Of course, like nearly all prospective-longitudinal research studies, Marr and colleagues’ observations do not license causal inferences. Aside from their immense practical value, well-designed intervention studies would afford a crucial opportunity to test whether reducing mothers’ perinatal stress is associated with positive consequences for infant temperament and, ultimately, mental illness.

Marr and colleagues’ results raise a host of challenging questions for future research. Are the observed changes in early-life temperament associated with meaningful differences in their children’s emotional health in adolescence and emerging adulthood? Are the offspring of mothers who experience the mid-/late-pregnancy trough in stress, for instance, less likely to develop internalizing disorders? How exactly might subtle nuances in the dynamics of perinatal stress shape children’s early-life emotional development? Are similar associations evident for fathers? To what extent are these prospective phenotypic associations a consequence of genetic confounding (31-33)? What exactly is meant by “stress” in this context? After all, the composite index of perinatal stress used in the American sample reflected a mixture of mood and anxiety symptoms; neuroticism; perceptions of uncertainty, uncontrollability, and overloading; difficulties coping with or regulating distress; and exposure to strains, hassles, and negative life events. Unpacking this conceptual complexity and demonstrating incremental validity over straightforward measures of maternal temperament and internalizing symptoms are important avenues for future research (34).

From a neurobiological angle, we might wonder how maternal stress “gets under the skin” to shape the development of the neural circuitry underlying negative emotionality. Marr and colleagues provide a preliminary answer to this question. Leveraging fMRI data collected from a subset of the American infants at 1 month of age, they investigated potential alterations in the intrinsic functional connectivity of the amygdala. The amygdala is particularly relevant because it is implicated in the development of anxiety and depression (35-37), is thought to mediate the impact of early-life adversities on negative emotionality (38), and shows a protracted course of postnatal development (39, 40). Among other findings, Marr and colleagues’ results suggest that the infants of Trajectory-3 mothers showed stronger functional connectivity between the amygdala and ventromedial prefrontal cortex, a region thought to play a mechanistically important role in processing safety cues; biasing the amygdala; and regulating fear, anxiety, and other negative emotions (41). This prospective association between maternal stress and infant brain function remained significant while controlling for the overall severity of perinatal stress, the other three maternal stress trajectories, and nuisance variance in gestational age at birth and infant age at the time of scanning. Collecting usable fMRI data from children is notoriously difficult, and the authors are to be commended for what was, in all likelihood, a Herculean scientific exercise (42). Nevertheless, it is clear that these findings—which capitalize on just 5.5 minutes of imaging data acquired from 60 infants who were further split, on the basis of their mothers’ perinatal stress patterns, into 6 sub-groups (n=9-32; Dr. Mollie Marr, personal communication; July 16, 2023)—represent a provisional hypothesis that will need to be rigorously replicated in larger and more nationally representative samples (43, 44). Addressing this challenge is likely to be facilitated by pooling data via new or existing biobanks (e.g., HBCD) or research consortia (e.g., ENIGMA). Moving forward, it is also worth reminding ourselves that the amygdala is a heterogeneous collection of nuclei linked by a network of microcircuits (45). Understanding its relevance to early-life stress and psychiatric risk requires that future studies more fully embrace this neuroanatomical complexity. Adopting more precise definitions of “stress” (46-48) and developing integrative cross-species models will also be crucial for understanding the molecular and cellular mechanisms that link variation in maternal experience to childhood mental health and disease (49-52).

Internalizing symptoms, diagnoses, and associated treatment-seeking are surging among children, adolescents, and young adults (53-56), drawing the attention of clinicians, scientists, insurers, and policymakers—from the Surgeon General to the President of the United States (57-59). While the underlying mechanisms remain elusive, Marr and colleagues’ report underscores the importance of developing a more complete understanding of the role that perinatal stress plays in the development of internalizing illness. Addressing this challenge will require a greater emphasis on mechanistically informative studies—including intervention, quasi-experimental, and genetic approaches—and the investment of resources commensurate with the established importance of children’s early emotional development for their lifelong health and wellbeing (15-17, 33, 60).

ACKNOWLEDGMENTS

Authors acknowledge assistance and critical feedback from K. DeYoung, E. Fried, L. Friedman, H. Goldsmith, G. Hancock, N. Kalin, M. Marr, and J. Smith. This work was partially supported by the National Institutes of Health (AA030042, MH131264, MH121409, DA041174, and MH115113), National Science Foundation (2145372 and 2145372), and University of Maryland.

REFERENCES

  • 1.Lee FS, Heimer H, Giedd JN, Lein ES, Sestan N, Weinberger DR, Casey BJ. Mental health. Adolescent mental health--opportunity and obligation. Science. 2014;346:547–549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, Il Shin J, Kirkbride JB, Jones P, Kim JH, Kim JY, Carvalho AF, Seeman MV, Correll CU, Fusar-Poli P. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2022;27:281–295. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.GBD 2019 Mental Disorders Collaborators. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137–150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.IHME: GBD Compare [Global causes of years lived with disability, 2019] [ http://ihmeuw.org/5zqd ]. Seattle, WA, University of Washington; 2023. [Google Scholar]
  • 5.NCS-R: National Comorbidity Study-Replication (NCS-R). Lifetime prevalence of DSM-IV/WMH-CIDI disorders by sex and cohort [ https://www.hcp.med.harvard.edu/ncs/ftpdir/NCS-R_Lifetime_Prevalence_Estimates.pdf ]. 2007.
  • 6.Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, Grant BF. Epidemiology of adult DSM-5 Major Depressive Disorder and its specifiers in the United States. JAMA Psychiatry. 2018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Dieleman JL, Cao J, Chapin A, Chen C, Li Z, Liu A, Horst C, Kaldjian A, Matyasz T, Scott KW, Bui AL, Campbell M, Duber HC, Dunn AC, Flaxman AD, Fitzmaurice C, Naghavi M, Sadat N, Shieh P, Squires E, Yeung K, Murray CJL. US health care spending by payer and health condition, 1996-2016. JAMA. 2020;323:863–884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Craske MG, Stein MB, Eley TC, Milad MR, Holmes A, Rapee RM, Wittchen H-U. Anxiety disorders. Nature Reviews Disease Primers. 2017;3:17024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Otte C, Gold SM, Penninx BW, Pariante CM, Etkin A, Fava M, Mohr DC, Schatzberg AF. Major depressive disorder. Nat Rev Dis Primers. 2016;2:16065. [DOI] [PubMed] [Google Scholar]
  • 10.Garakani A, Murrough J, Freire R, Thom R, Larkin K, Buono F, Iosifescu D. Pharmacotherapy of anxiety disorders: Current and emerging treatment options. Frontiers in Psychiatry. 2020;11:595584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sartori SB, Singewald N. Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders. Pharmacology & Therapeutics. 2019;204:107402. [DOI] [PubMed] [Google Scholar]
  • 12.James AC, Reardon T, Soler A, James G, Creswell C. Cognitive behavioural therapy for anxiety disorders in children and adolescents. The Cochrane database of systematic reviews. 2020;11:Cd013162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ginsburg GS, Becker-Haimes EM, Keeton C, Kendall PC, Iyengar S, Sakolsky D, Albano AM, Peris T, Compton SN, Piacentini J. Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes. Journal of the American Academy of Child and Adolescent Psychiatry. 2018;57:471–480. [DOI] [PubMed] [Google Scholar]
  • 14.Singewald N, Sartori SB, Reif A, Holmes A. Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder. Neuropharmacology. 2023;226:109418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Luby JL, Rogers C, McLaughlin KA. Environmental conditions to promote healthy childhood brain/behavioral development: Informing early preventive interventions for delivery in routine care. Biol Psychiatry Glob Open Sci. 2022;2:233–241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Rapee RM, Creswell C, Kendall PC, Pine DS, Waters AM. Anxiety disorders in children and adolescents: A summary and overview of the literature. Behaviour Research and Therapy. in press. [DOI] [PubMed] [Google Scholar]
  • 17.Gee DG, Cohodes EM. Caregiving influences on development: A sensitive period for biological embedding of predictability and safety cues. Current Directions in Psychological Science. 2021;30:376–383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kahhalé I, Barry KR, Hanson JL. Positive parenting moderates associations between childhood stress and corticolimbic structure. PNAS nexus. 2023;2:pgad145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Van den Bergh BRH, van den Heuvel MI, Lahti M, Braeken M, de Rooij SR, Entringer S, Hoyer D, Roseboom T, Räikkönen K, King S, Schwab ME. Prenatal developmental origins of behavior and mental health: The influence of maternal stress in pregnancy. Neuroscience & Biobehavioral Reviews. 2020;117:26–64. [DOI] [PubMed] [Google Scholar]
  • 20.Marr MC, Graham AM, Feczko E, Nolvi S, Thomas E, Sturgeon D, Schifsky E, Rasmussen JM, Gilmore JH, Styner M, Entringer S, Wadhwa PD, Korja R, Karlsson H, Karlsson L, Buss C, Fair DA. Maternal perinatal stress trajectories impact negative affect and amygdala development in offspring. American Journal of Psychiatry. in press. [DOI] [PubMed] [Google Scholar]
  • 21.Feczko E, Miranda-Dominguez O, Marr M, Graham AM, Nigg JT, Fair DA. The heterogeneity problem: Approaches to identify psychiatric subtypes. Trends Cogn Sci. 2019;23:584–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Shiner RL: What are the dimensions and bases for lasting individual differences in emotion? in The Nature of Emotion. Edited by Fox AS, Lapate RC, Shackman AJ, Davidson RJ. 2nd ed. New York, NY, Oxford University Press; 2018. pp. 61–64. [Google Scholar]
  • 23.Klein DN, Dougherty LR, Kessel EM, Silver J, Carlson GA. A transdiagnostic perspective on youth irritability. Current Directions in Psychological Science. 2021;30:437–443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tan E, Zeytinoglu S, Morales S, Buzzell GA, Almas AN, Degnan KA, Chronis-Tuscano A, Henderson H, Pine DS, Fox NA. Social versus non-social behavioral inhibition: Differential prediction from early childhood of long-term psychosocial outcomes. Developmental Science. in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fox AS, Kalin NH. A translational neuroscience approach to understanding the development of social anxiety disorder and its pathophysiology. American Journal of Psychiatry. 2014;171:1162–1173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and adolescents: Developmental issues and implications for DSM-V. Psychiatric Clinics of North America. 2009;32:483–524. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gee DG. Early adversity and development: Parsing heterogeneity and identifying pathways of risk and resilience. Am J Psychiatry. 2021;178:998–1013. [DOI] [PubMed] [Google Scholar]
  • 28.Cohodes EM, Kitt ER, Baskin-Sommers A, Gee DG. Influences of early-life stress on frontolimbic circuitry: Harnessing a dimensional approach to elucidate the effects of heterogeneity in stress exposure. Developmental psychobiology. 2021;63:153–172. [DOI] [PubMed] [Google Scholar]
  • 29.McLaughlin KA, Sheridan MA, Humphreys KL, Belsky J, Ellis BJ. The value of dimensional models of early experience: Thinking clearly about concepts and categories. Perspect Psychol Sci. 2021;16:1463–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Smith KE, Pollak SD. Rethinking concepts and categories for understanding the neurodevelopmental effects of childhood adversity. Perspect Psychol Sci. 2021;16:67–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Scarr S, McCartney K. How people make their own environments: a theory of genotype greater than environment effects. Child Dev. 1983;54:424–435. [DOI] [PubMed] [Google Scholar]
  • 32.Hart SA, Little C, van Bergen E. Nurture might be nature: cautionary tales and proposed solutions. npj Science of Learning. 2021;6:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Rice F. The intergenerational transmission of anxiety disorders and major depression. Am J Psychiatry. 2022;179:596–598. [DOI] [PubMed] [Google Scholar]
  • 34.Shackman AJ, Fox AS. Getting serious about variation: Lessons for clinical neuroscience. Trends in Cognitive Sciences. 2018;22:368–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Grogans SE, Fox AS, Shackman AJ. The amygdala and depression: A sober reconsideration. Am J Psychiatry. 2022;179:454–457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hur J, Stockbridge MD, Fox AS, Shackman AJ. Dispositional negativity, cognition, and anxiety disorders: An integrative translational neuroscience framework. Progress in Brain Research. 2019;247:375–436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Shackman AJ, Fox AS. Two decades of anxiety neuroimaging research: New insights and a look to the future American Journal of Psychiatry. 2021;178:106–109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Fox AS, Oler JA, Shackman AJ, Shelton SE, Raveendran M, McKay DR, Converse AK, Alexander AL, Davidson RJ, Blangero J, Rogers J, Kalin NH. Intergenerational neural mediators of early-life anxious temperament. Proceedings of the National Academy of Sciences USA. 2015;112:9118–9122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Avino TA, Barger N, Vargas MV, Carlson EL, Amaral DG, Bauman MD, Schumann CM. Neuron numbers increase in the human amygdala from birth to adulthood, but not in autism. Proc Natl Acad Sci U S A. 2018;115:3710–3715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chareyron LJ, Banta Lavenex P, Amaral DG, Lavenex P. Life and death of immature neurons in the juvenile and adult primate amygdala. International journal of molecular sciences. 2021;22:6691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Tashjian SM, Zbozinek TD, Mobbs D. A decision architecture for safety computations. Trends Cogn Sci. 2021;25:342–354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Pfeifer JH, Allen NB, Byrne ML, Mills KL. Modeling developmental change: Contemporary approaches to key methodological challenges in developmental neuroimaging. Developmental Cognitive Neuroscience. 2018;33:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Marek S, Tervo-Clemmens B, Calabro FJ, Montez DF, Kay BP, Hatoum AS, Donohue MR, Foran W, Miller RL, Hendrickson TJ, Malone SM, Kandala S, Feczko E, Miranda-Dominguez O, Graham AM, Earl EA, Perrone AJ, Cordova M, Doyle O, Moore LA, Conan GM, Uriarte J, Snider K, Lynch BJ, Wilgenbusch JC, Pengo T, Tam A, Chen J, Newbold DJ, Zheng A, Seider NA, Van AN, Metoki A, Chauvin RJ, Laumann TO, Greene DJ, Petersen SE, Garavan H, Thompson WK, Nichols TE, Yeo BTT, Barch DM, Luna B, Fair DA, Dosenbach NUF. Reproducible brain-wide association studies require thousands of individuals. Nature. 2022;603:654–660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.LeWinn KZ, Sheridan MA, Keyes KM, Hamilton A, McLaughlin KA. Sample composition alters associations between age and brain structure. Nature Communications. 2017;8:874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Fox AS, Oler JA, Tromp DP, Fudge JL, Kalin NH. Extending the amygdala in theories of threat processing. Trends Neurosci. 2015;38:319–329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Kagan J Why stress remains an ambiguous concept. Perspectives on Psychological Science. 2016;11:464–465. [DOI] [PubMed] [Google Scholar]
  • 47.Kagan J An overly permissive extension. Perspectives on Psychological Science. 2016;11:442–450. [DOI] [PubMed] [Google Scholar]
  • 48.Fox AS, Lapate RC, Davidson RJ, Shackman AJ: The nature of emotion: A research agenda for the 21st century. in The nature of emotion Fundamental questions. Edited by Fox AS, Lapate RC, Shackman AJ, Davidson RJ. 2nd ed. New York, NY, Oxford University Press; 2018. pp. 403–417. [Google Scholar]
  • 49.Fox AS, Shackman AJ. The central extended amygdala in fear and anxiety: Closing the gap between mechanistic and neuroimaging research. Neuroscience Letters. 2019;693:58–67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Meyer HC, Odriozola P, Cohodes EM, Mandell JD, Li A, Yang R, Hall BS, Haberman JT, Zacharek SJ, Liston C, Lee FS, Gee DG. Ventral hippocampus interacts with prelimbic cortex during inhibition of threat response via learned safety in both mice and humans. Proc Natl Acad Sci U S A. 2019;116:26970–26979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Callaghan B, Meyer H, Opendak M, Van Tieghem M, Harmon C, Li A, Lee FS, Sullivan RM, Tottenham N. Using a developmental ecology framework to align fear neurobiology across species. Annu Rev Clin Psychol. 2019;15:345–369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Meyer HC, Fields A, Vannucci A, Gerhard DM, Bloom PA, Heleniak C, Opendak M, Sullivan R, Tottenham N, Callaghan BL, Lee FS. The added value of crosstalk between developmental circuit neuroscience and clinical practice to inform the treatment of adolescent anxiety. Biol Psychiatry Glob Open Sci. 2023;3:169–178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Brody DJ, Gu Q. Antidepressant use among adults: United States, 2015–2018. National Center for Health Statistics Data Brief. 2020;377:1–7. [PubMed] [Google Scholar]
  • 54.Binkley C, Fenn L: Colleges struggle with soaring student demand for counseling. in Associated Press; 2019. [Google Scholar]
  • 55.SAMHSA: Key substance use and mental health indicators in the United States: Results from the 2018 National Survey on Drug Use and Health. Rockville, MD, Center for Behavioral Health Statistics and Quality; 2019. [Google Scholar]
  • 56.Underwood JM, Brener N, Thornton J, Harris WA, Bryan LN, Shanklin SL, Deputy N, Roberts AM, Queen B, Chyen D, Whittle L, Lim C, Yamakawa Y, Leon-Nguyen M, Kilmer G, Smith-Grant J, Demissie Z, Everett Jones S, Clayton H, Dittus P. Overview and Methods for the Youth Risk Behavior Surveillance System — United States, 2019. Morbidity and Mortality Weekly Report. 2020;69(S1):1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Office of the President of the U.S.A. : FACT SHEET: President Biden to announce strategy to address our national mental health crisis, as part of unity agenda in his first state of the union [ https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/01/fact-sheet-president-biden-to-announce-strategy-to-address-our-national-mental-health-crisis-as-part-of-unity-agenda-in-his-first-state-of-the-union ]. Washington, DC, Office of the President of the U.S.A.,; 2022. [Google Scholar]
  • 58.U.S. Surgeon General: Protecting youth mental health: The U.S. Surgeon General’s advisory [ https://www.ncbi.nlm.nih.gov/books/NBK575984/ ]. Washington, DC, U.S. Department of Health and Human Services; 2021. [PubMed] [Google Scholar]
  • 59.BlueCross BlueShield: New research underscores mental health challenges facing American youth [ https://www.bcbs.com/the-health-of-america/articles/new-research-underscores-mental-health-challenges-facing-american ]. BlueCross BlueShield; 2023. [Google Scholar]
  • 60.Ridley M, Rao G, Schilbach F, Patel V. Poverty, depression, and anxiety: Causal evidence and mechanisms. Science. 2020;370. [DOI] [PubMed] [Google Scholar]

RESOURCES